Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Hackett

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
American Journal of Translational Research|February 4, 2014
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE)Charles Hackett, Julia Knight, Yang Mao-Draayer
Journal of the Neurological Sciences|April 16, 2011
Cross-talk between CD4+ T-cells and neural stem/progenitor cellsJulia Knight, Charles Hackett, Jocelyn Breton, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
American Journal of Translational Research|February 4, 2014
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE)Charles Hackett, Julia Knight, Yang Mao-Draayer
Journal of the Neurological Sciences|April 16, 2011
Cross-talk between CD4+ T-cells and neural stem/progenitor cellsJulia Knight, Charles Hackett, Jocelyn Breton, et al.
Pageof 1